PBA
Paradigm Biocapital Advisors’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110M | Buy |
3,372,837
+1,676,356
| +99% | +$54.5M | 4.68% | 6 |
|
|
2025
Q1 | $64.1M | Buy |
1,696,481
+273,694
| +19% | +$10.3M | 2.93% | 10 |
|
|
2024
Q4 | $116M | Buy |
1,422,787
+795,055
| +127% | +$65.1M | 4.05% | 8 |
|
|
2024
Q3 | $71.7M | Buy |
627,732
+530
| +0.1% | +$60.6K | 2.43% | 12 |
|
|
2024
Q2 | $47.4M | Sell |
627,202
-612,793
| -49% | -$46.3M | 1.81% | 18 |
|
|
2024
Q1 | $84.7M | Buy |
+1,239,995
| New | +$84.7M | 2.98% | 16 |
|